Skip to main content

Table 5 Preliminary supplemental infection prevention and control measures for CRE “at-risk” patients with or without known microbiological results

From: Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control

Intervention (Evidence source) Comments on measure and implementation
Pre-emptive isolation of patients on admission (SR) Isolation in single rooms either upon admission or when patients are actively screened for carriage of CRE
Decision for patient placement should be made after individualised risk assessment by, and consultation with the IPC team
En suite or bathrooms designated for use by known carriers, or commodes are strongly suggested for all patients on contact precautions for CRE
Active screening on admission (SR)a Active screening of all “at-risk” patients on admission to healthcare setting
Contact precautions (SR) Contact precautions should be used for direct contact with patient or their environment
En suite or bathrooms designated for use by known carriers, or commodes are strongly suggested for all patients on contact precautions for CRE
  1. SR Systematic review, EO Expert opinion
  2. aActive screening encompasses rectal screening, as well as screening from any other site which is either actively infected, e.g. draining wounds, or considered to be colonised
  3. (Please see Additional file 1: Supplementary Table S3 in the supplementary section, for a printable summary of these measures)